Kshethra Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 234.38%
- Profit Growth 307.25%
- Ebitda 675.66%
- Net Worth 109.81%
- Total Assets 113.57%
About Kshethra Life Sciences
Kshethra Life Sciences Private Limited (KLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 February 2021 (Three years and 11 months 16 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Mayil Dorai and Umesh Nayak serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2021PTC144508
-
Company No.
144508
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Feb 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Kshethra Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Nayak
|
Additional Director | 18-May-2024 | Current |
|
Mayil Dorai
|
Director | 23-Nov-2022 | Current |
Financial Performance of Kshethra Life Sciences.
Kshethra Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 234.38% increase. The company also saw a substantial improvement in profitability, with a 307.25% increase in profit. The company's net worth Soared by an impressive increase of 109.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kshethra Life Sciences?
In 2023, Kshethra Life Sciences had a public holding of 9.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kalzen Circulartech Private LimitedUmesh Nayak is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2024 | Others | ₹5.00 M | Open |
How Many Employees Work at Kshethra Life Sciences?
Kshethra Life Sciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kshethra Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kshethra Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
